NEW YORK (GenomeWeb) – Taconic Biosciences has signed a license agreement with ERS Genomics to use ERS' CRISPR-Cas9 technology to generate unique murine models.

Under the agreement, Taconic receives a worldwide, non-exclusive license to CRISPR-Cas9 intellectual property often referred to as the UC Berkeley patent. ERS founder Emmanuelle Charpentier is a co-inventor of the technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.